May 8, 2023
Cytel brings together Quantitative, Computational, Regulatory, and Strategic Drug Development Capabilities into Modern..
February 7, 2023
GSK plans expansion of Solara clinical trial strategy platform to optimize design selection across therapeutic areas
February 6, 2023
Quantitative bias analysis (QBA) is a potential and likely breakthrough in real-world evidence. This was the conclusion..
January 12, 2023
WALTHAM, MASSACHUSETTS — Cytel Inc., a leading provider of innovative clinical trial designs, advanced analytics, and..
November 16, 2022
Solara clinical trial strategy platform recognized for transformative innovation WALTHAM, MASS - Cytel Inc., a..
November 8, 2022
WALTHAM, MASSACHUSETTS -- A new partnership between Cytel Inc., a global health analytics firm, and South Korea's Trial..